XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on ...
XORTX Therapeutics Inc ( (TSE:XRTX)) has shared an update. On April 21, 2026, XORTX Therapeutics Inc. announced it has regained compliance with Nasdaq’s minimum bid price requirement, which mandates a ...
VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Xortx Therapeutics (NASDAQ:XRTX) stock is sliding lower on Monday as the pharmaceutical company’s shares come off of a recent rally. Shares of XRTX stock closed out normal trading hours on Friday up ...
XORTX Therapeutics Inc. Annual stock financials by MarketWatch. View the latest XRTX financial statements, income statements and financial ratios.
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results